1. Home
  2. NEUE vs GBIO Comparison

NEUE vs GBIO Comparison

Compare NEUE & GBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NEUE
  • GBIO
  • Stock Information
  • Founded
  • NEUE 2015
  • GBIO 2016
  • Country
  • NEUE United States
  • GBIO United States
  • Employees
  • NEUE N/A
  • GBIO N/A
  • Industry
  • NEUE
  • GBIO Biotechnology: Pharmaceutical Preparations
  • Sector
  • NEUE
  • GBIO Health Care
  • Exchange
  • NEUE NYSE
  • GBIO Nasdaq
  • Market Cap
  • NEUE 60.7M
  • GBIO 64.8M
  • IPO Year
  • NEUE 2021
  • GBIO 2020
  • Fundamental
  • Price
  • NEUE $7.35
  • GBIO $0.61
  • Analyst Decision
  • NEUE Hold
  • GBIO Strong Buy
  • Analyst Count
  • NEUE 1
  • GBIO 2
  • Target Price
  • NEUE $7.00
  • GBIO $6.50
  • AVG Volume (30 Days)
  • NEUE 19.3K
  • GBIO 453.7K
  • Earning Date
  • NEUE 03-06-2025
  • GBIO 03-05-2025
  • Dividend Yield
  • NEUE N/A
  • GBIO N/A
  • EPS Growth
  • NEUE N/A
  • GBIO N/A
  • EPS
  • NEUE N/A
  • GBIO N/A
  • Revenue
  • NEUE $996,890,000.00
  • GBIO $18,582,000.00
  • Revenue This Year
  • NEUE N/A
  • GBIO $212.74
  • Revenue Next Year
  • NEUE $9.44
  • GBIO N/A
  • P/E Ratio
  • NEUE $2.16
  • GBIO N/A
  • Revenue Growth
  • NEUE N/A
  • GBIO 514.08
  • 52 Week Low
  • NEUE $3.79
  • GBIO $0.59
  • 52 Week High
  • NEUE $11.35
  • GBIO $4.65
  • Technical
  • Relative Strength Index (RSI)
  • NEUE 61.05
  • GBIO 28.72
  • Support Level
  • NEUE $7.30
  • GBIO $0.60
  • Resistance Level
  • NEUE $7.66
  • GBIO $0.75
  • Average True Range (ATR)
  • NEUE 0.07
  • GBIO 0.07
  • MACD
  • NEUE -0.05
  • GBIO 0.00
  • Stochastic Oscillator
  • NEUE 26.19
  • GBIO 9.63

About NEUE NEUEHEALTH INC

NeueHealth Inc is a value driven healthcare company grounded in the belief that all health consumers are entitled to high-quality, coordinated care. By uniquely aligning the interests of health consumers, providers, and payors, NeueHealth helps to make healthcare accessible and affordable to all populations across the ACA Marketplace, Medicare, and Medicaid. It also enables independent providers and medical groups to thrive in performance-based arrangements through a suite of technology and services scaled centrally and deployed locally.

About GBIO Generation Bio Co.

Generation Bio Co is a genetics medicine company that is focused on creating gene therapies to provide durable and redosable treatments for patients suffering from rare and untreated diseases. The company focuses on liver and retina-related diseases. It is developing two distinct and complementary platforms that It believes will enable highly differentiated therapeutic applications. Its first platform is a potent, highly selective ctLNP delivery system for nucleic acids, which is designed to avoid off-target clearance by the liver and spleen, enabling ctLNPs to persist in systemic circulation and allowing for highly selective and potent ligand-driven targeting to specific tissues and cell types. Its second platform is its novel iqDNA, which is an optimized variant of its ceDNA.

Share on Social Networks: